We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Endothelin receptors in renal interstitial cells do not contribute to the development of fibrosis during experimental kidney disease

    Renal interstitial fibrosis is characterized by the development of myofibroblasts, originating from resident renal and immigrating cells....

    Thomas H. Neder, Julia Schrankl, ... Charlotte Wagner in Pflügers Archiv - European Journal of Physiology
    Article Open access 06 August 2021
  2. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis

    Kidney fibrosis is the hallmark of chronic kidney disease (CKD) progression, whereas no effective anti-fibrotic therapies exist. Recent evidence has...

    Bo Wang, Li-na Yang, ... Liang Ma in Acta Pharmacologica Sinica
    Article 11 September 2023
  3. Endothelium-specific deletion of p62 causes organ fibrosis and cardiac dysfunction

    Background

    The autophagy adapter SQSTM1/p62 is crucial for maintaining homeostasis in various organs and cells due to its protein–protein interaction...

    **g Feng, Yan Li, ... Qiang Wan in Journal of Translational Medicine
    Article Open access 16 February 2024
  4. DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis

    Renal fibrosis is the final pathological change in renal disease, and aging is closely related to renal fibrosis. Mitochondrial dysfunction has been...

    Ming Yang, Yan Liu, ... Lin Sun in Acta Pharmacologica Sinica
    Article 10 January 2024
  5. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury

    Age is a predominant risk factor for acute kidney injury (AKI), yet the biological mechanisms underlying this risk are largely unknown. Clonal...

    Caitlyn Vlasschaert, Cassianne Robinson-Cohen, ... Alexander G. Bick in Nature Medicine
    Article Open access 07 March 2024
  6. An animal-free preclinical drug screening platform based on human precision-cut kidney slices

    Objective

    Renal fibrosis is one of the main pathophysiological processes underlying the progression of chronic kidney disease and kidney allograft...

    Henricus A. M. Mutsaers, Michael Schou Jensen, ... Rikke Nørregaard in BMC Research Notes
    Article Open access 20 March 2023
  7. Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?

    Metabolic acidosis is a frequent complication in non-transplant chronic kidney disease (CKD) and after kidney transplantation. It occurs when net...

    Christian Kuhn, Nilufar Mohebbi, Alexander Ritter in Pflügers Archiv - European Journal of Physiology
    Article Open access 27 January 2024
  8. The SOX4/EZH2/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury

    Epigenetic regulation is reported to play a significant role in the pathogenesis of various kidney diseases, including renal cell carcinoma, acute...

    **nzhou Yan, Yuqi **a, ... Fan Cheng in Journal of Translational Medicine
    Article Open access 02 January 2024
  9. Sorafenib and edaravone protect against renal fibrosis induced by unilateral ureteral obstruction via inhibition of oxidative stress, inflammation, and RIPK-3/MLKL pathway

    Renal fibrosis is the common endpoint of nearly all chronic and progressive nephropathies. Cell death and sterile inflammation are the main...

    Mohamed A. Abou Taha, Fares E.M. Ali, ... El-Sayed Akool in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 14 June 2024
  10. Silencing HE4 alleviates the renal fibrosis in lupus nephritis mice by regulating the C3/MMPs/prss axis

    To explore the regulatory effect of human epididymis protein 4 (HE4) on renal fibrosis in mice with lupus nephritis (LN) and the underlying...

    Yixia Li, **aorong Zhong, Feng Yang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 29 December 2023
  11. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy

    Glomerulosclerosis and tubulointerstitial fibrosis (TIF) are closely involved in the development of diabetic nephropathy (DN). Moreover, the...

    **g-Yi Zeng, Yu Wang, ... **ao-Rong Bao in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 22 November 2023
  12. The down-regulation of XBP1, an unfolded protein response effector, promotes acute kidney injury to chronic kidney disease transition

    Background

    The activation of the unfolded protein response (UPR) is closely linked to the pathogenesis of renal injuries. However, the role of XBP1, a...

    Jia-Huang Chen, Chia-Hsien Wu, ... Chih-Kang Chiang in Journal of Biomedical Science
    Article Open access 28 June 2022
  13. PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway

    Truncated transforming growth factor β receptor type II (tTβRII), serving as a trap for binding excessive transforming growth factor β1 (TGF-β1) by...

    Bing Wang, **aohua Wang, ... Haifeng Liu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 04 July 2023
  14. N6-methyladenosine methylation in kidney injury

    Multiple mechanisms are involved in kidney damage, among which the role of epigenetic modifications in the occurrence and development of kidney...

    Qimeng Wang, **aoting Fan, ... Rong Wang in Clinical Epigenetics
    Article Open access 21 October 2023
  15. Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

    Background

    Renal interstitial fibrosis (RIF) is a common pathway to end-stage renal disease regardless of the initial etiology. Currently, the...

    Yilin Tao, Chengyuan Tang, ... Ying Li in Molecular Medicine
    Article Open access 09 May 2023
  16. Anthocyanin improves kidney function in diabetic kidney disease by regulating amino acid metabolism

    Background

    Diabetic kidney disease (DKD) is among the most important causes for chronic kidney disease. Anthocyanins (ANT) are polyphenolic compounds...

    Yi-** Li, Yong-** Lu, ... Ting Zhu in Journal of Translational Medicine
    Article Open access 05 November 2022
  17. Fibrosis in Liver and Pancreas: a Review on Pathogenic Significance, Diagnostic Options, and Current Management Strategies

    Inflammation is one of the most natural ways of the body’s biological response against invading foreign pathogens or injured cells which eventually...

    Tiasha Dasgupta, Venkatraman Manickam in Inflammation
    Article 03 January 2023
  18. Inhalation Lenalidomide-Loaded Liposome for Bleomycin-Induced Pulmonary Fibrosis Improvement

    Idiopathic pulmonary fibrosis (IPF) is a progressive, fibrotic interstitial lung disease with unclear etiology and increasing prevalence. Pulmonary...

    Zhilin Luo, Liyuan Ji, ... Cheng Yang in AAPS PharmSciTech
    Article 16 November 2023
  19. Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting β-catenin K49 deacetylation

    Renal interstitial fibrosis is the common pathological process of various chronic kidney diseases to end-stage renal disease. Inhibition of...

    Dan-Qian Chen, Lin Chen, ... ** Li in Acta Pharmacologica Sinica
    Article Open access 05 December 2022
  20. COVID-19-Induced Kidney Disease: Ethnopharmacological Intervention to Ameliorate Kidney Damage and Improve Kidney Function

    The coronavirus disease 2019 (COVID-19) pandemic has left a trail of disaster in its wake. Not only has it resulted in a large-scale loss of life,...
    Chapter 2023
Did you find what you were looking for? Share feedback.